Hot flushes, hormone therapy and alternative treatments: 30 years of experience from Sweden

L Lindh-Åstrand, M Hoffmann, M Hammar… - …, 2015 - Taylor & Francis
Objectives The use of hormone therapy (HT) for hot flushes has changed dramatically over
the past five decades. In this cross-sectional questionnaire study, the aim was to describe …

Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression

CO Ladd, DJ Newport, KA Ragan… - Depression and …, 2005 - Wiley Online Library
Perimenopause is often marked by vasomotor symptoms and dysphoria. Antidepressant
studies have demonstrated decreased frequency and severity of hot flashes in breast cancer …

Low-dose transdermal estradiol for vasomotor symptoms: a systematic review

J Corbelli, N Shaikh, C Wessel, R Hess - Menopause, 2015 - journals.lww.com
Objective This review aims to determine the effectiveness of low-dose transdermal estrogen
versus placebo in postmenopausal women with moderate to severe hot flashes. Methods …

Androgens and estrogens in relation to hot flushes during the menopausal transition

I Øverlie, MH Moen, A Holte, A Finset - Maturitas, 2002 - Elsevier
In this paper, the association of hormones to vasomotor complaints during the menopausal
transition is discussed. Fifty-seven regularly menstruating women without history of hormone …

Managing menopausal symptoms: hot flushes and night sweats.

J Brockie - Nursing Standard, 2013 - search.ebscohost.com
Menopausal hot flushes and night sweats are the most common symptoms of the
menopause, and a minority of women find them distressing and seek treatment. Hormone …

Nonestrogen management of menopausal symptoms

SL Hendrix - Endocrinology and metabolism clinics of North America, 1997 - Elsevier
Only 15% of menopausal women use hormone replacement therapy for symptomatic relief
of hot flushes, night sweats, vaginal dryness, and other menopausal symptoms …

Nonhormonal therapies for hot flashes in menopause

DG Carroll - American family physician, 2006 - aafp.org
Numerous reports in the medical literature and popular media have discussed the
effectiveness of various nonhormonal agents in reducing menopausal hot flash symptoms …

[引用][C] Elevated α2-adrenergic responsiveness in menopausal hot flushes: pharmacologic and biochemical studies

RR Freedman, S Woodward - … : The Pathophysiological Basis of Clinical Disorders …, 1992

Menopausal changes, quality of life, and hormone therapy

LE Nachtigall, MJ Nachtigall - Clinical obstetrics and gynecology, 2004 - journals.lww.com
Estrogen loss that occurs with the onset of the menopause transition is associated with
multiple physiologic changes. These changes affect quality of life (QOL) and general well …

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo …

JAV Pinkerton, G Constantine, E Hwang, JC Ru-fong… - Menopause, 2013 - journals.lww.com
Objective The aim of this study was to assess the 12-week efficacy of desvenlafaxine in
treating moderate to severe vasomotor symptoms and the clinical relevance of …